An efficient, flexible, modern laboratory that’s brimming with state-of-the-art equipment and follows the latest trends in analyticalchemistry while respecting good old-fashioned chemical processes. Welcome to QUINTA-ANALYTICA’s R&D department.

The core task of this department comprises the development of new analytical methods where (U)HPLC equipment is used for a variety of known detectors like DAD-UV, fluorescence, or ELSD. And for the cases where HPLC is not enough, our LC/MS system with linear ion trap mass spectrometer can be fired up in order to improve selectivity or specificity, especially in trace analyses.

Sounds complex, and indeed it is; but Libor Hoplíček and his team of innovative experts work tirelessly to carry out research in many interesting areas, including the determination and isolation of impurities, accelerated stabilities and degradation studies, de-formulation (reverse engineering) studies, and extractable/leachable analyses to name just a few.

If you’re developing volatile compounds, struggling with in-vitro testing, or looking for someone who has Franz diffusion cell expertise for your permeation studies, look no further. Contact Libor and his team for a no-obligation discussion.

Additional News

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

  • 11 September 2025

    Meet us at CPHI 2025

    This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too – visit us in the Contract Manufacturing Hall 5.1, Stand F1.

  • 8 September 2025

    Quinta-Analytica successfully passed two onsite FDA inspections

    In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA).